Mexico Neurology Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.20 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Mexico Neurology Devices Market Analysis
The Mexico neurology devices market is expected to register a CAGR of 6.2% during the forecast period.
- The COVID-19 pandemic significantly impacted neurology care in Mexico during the early phase, which in turn impacted the usage of neurology devices as well. For instance, according to an article published by PubMed Central in April 2021, a study was conducted in Mexico, which showed that the prevalence of new neurologic complications in hospitalized patients with COVID-19 was very high during the early pandemic. Thus, the COVID-19 pandemic significantly impacted the market initially; however, as the pandemic has currently subsided, neurology care is going back to normal in Mexico. Hence, the studied market is expected to have stable growth during the forecast period of the study.
- The key factors propelling the growth of the market are the increasing incidence of neurological disorders, the rising geriatric population, and the rising technological advancements in neurological devices.
- The increasing incidence of neurological disorders like brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson's disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumors, and stroke is the major factor driving the market growth. For instance, according to an article published by PubMed Central in June 2022, a study was conducted in Mexico, which showed that the prevalence of intracerebral hemorrhage and cerebral venous thrombosis was 23.1% and 0.2%, respectively, in patients suffering from acute stroke.
- Furthermore, according to an article published by Cureus in October 2022, glioblastoma or brain tumors represent the most frequent and aggressive intracranial neoplasia, and it has a high prevalence in Mexico. Thus, the high prevalence of such neurological disorders is expected to enhance the usage of neurological devices. Moreover, as these neurological diseases mostly occur in the elderly population, the rising geriatric population in the country is also expected to enhance market growth.
- Thus, the aforementioned factors, such as the rising prevalence of neurological disorders and the increasing research and development activities, are expected to boost the market growth during the forecast period of the study. However, the high cost of equipment is expected to impede the market growth.
Mexico Neurology Devices Market Trends
Sacral Nerve Stimulation Devices Segment is Expected to Have a Significant Market Share During the Forecast Period
- The sacral nerve stimulation devices are mostly used for patients for whom drug therapy or other medications are unsuccessful. It is performed with the help of a small device, which is capable of sending electrical impulses to the targeted sacral nerves located in the lower back region. These devices are found to be successful in treating bladder problems. Hence, the sacral nerve stimulation devices segment is expected to grow with increasing incidences of overactive bladder and bowel incontinence.
- According to an article published by the Multidisciplinary Digital Publishing Institute (MDPI) in January 2022, Mexican adults aged 50 years or older have a high incidence of urinary incontinence, and it is also indicated that depression and falls could decrease the incidence of urinary incontinence. Thus, the increasing rate of urinary incontinence among older adults is expected to boost the usage of sacral nerve stimulation, as sacral nerve stimulation is often used for its treatment.
- Furthermore, according to an article published by Taylor & Francis Online in February 2023, a study was conducted in Mexico that examined the relationship between gender and the different urinary incontinence subtypes in community residents of the country in people aged 50 years old and above, it was found that in elderly females, mixed urinary incontinence had the highest incidence rate of 8.7%, which increased with age from 6.9% in 50 to 59-year-olds to 11.8% in 90year olds. Moreover, the rising adult and geriatric population in the country is also expected to boost segment growth, as these diseases are mainly associated with these age groups, and sacral nerve stimulation is often used as a treatment option for these diseases.
- Hence, the aforementioned factors, such as the rising prevalence of fecal incontinence and urinary incontinence and the rising adult and geriatric population, are expected to boost the segment growth during the forecast period of the study.
Deep Brain Stimulation Devices Segment is Expected to Have a Significant Growth During the Forecast Period
- Deep brain stimulation (DBS) is a neurosurgical technique that regulates neuron activity by using internal pulse generators to electrodes in specific target areas of the brain. These devices are used for the treatment of various neurological diseases such as dystonia, Alzheimer's disease, Parkinson's disease, and epilepsy, among others. Thus, the rising prevalence of such neurological disorders in Mexico and the rising geriatric population are expected to boost the segment growth.
- For instance, according to an article published by ScienceDirect in March 2022, a study was conducted in Mexico which showed that the prevalence rate of Parkinson's disease in the urban parts of Mexico ranged from 2.1% in the 65-69-year-old age group to 11.9% in 75-79-year-old age group. Thus, the high prevalence of Parkinson's disease in the country is expected to boost segment growth.
- Furthermore, the high prevalence of Alzheimer's in the country is expected to increase the demand for deep brain stimulation and likely boost the segment to growth. For instance, as per the study report published by the Journal of Alzheimer's Disease in September 2022, in Mexico, 7.8% of people were estimated to have dementia and have the symptoms of Alzheimer's disease. The prevalence of dementia was higher in women than in men.
- Similarly, as per the report published by gob.mx in October 2021, it is estimated that in Mexico, approximately 1.3 million people suffer from Alzheimer's disease, which represents between 60% to 70% of dementia diagnoses and affects people over 65 years of age. Thus, the high prevalence of Alzheimer's disease increases the usage of deep brain stimulation devices and is expected to have a significant impact on the market growth.
- Hence, the aforementioned factors, such as the rising prevalence of Alzheimer's disease and Parkinson's disease and the rising geriatric population, are expected to boost the segment growth during the forecast period of the study.
Mexico Neurology Devices Industry Overview
The Mexico neurology devices market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. Some of the major players are B. Braun SE, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, Abbott Laboratories, Johnson and Johnson, and Smith & Nephew, among others.
Mexico Neurology Devices Market Leaders
Abbott Laboratories
Boston Scientific Corporation
Stryker Corporation
Medtronic PLC
B. Braun SE
*Disclaimer: Major Players sorted in no particular order
Mexico Neurology Devices Market News
- December 2022: Hospital Israelita Albert Einstein started a clinical trial study in collaboration with Biogen in Mexico for longitudinal data collection in pediatric and adult patients with spinal muscular atrophy.
- March 2022: BioElectronics Corporation announced that its distribution partner in Mexico has received authorization from the Mexican Food and Drug Administration (FDA) (Cofepris), which allowed for the importation of the RecoveryRx neuromodulation device into Mexico.
Mexico Neurology Devices Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Neurological Disorders
4.2.2 Technological Advancements in Neurological Devices
4.3 Market Restraints
4.3.1 High Cost of Equipment
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value in USD)
5.1 By Type of Device
5.1.1 Cerebrospinal Fluid Management Devices
5.1.2 Interventional Neurology Devices
5.1.2.1 Interventional/Surgical Simulators
5.1.2.2 Neurothrombectomy Devices
5.1.2.3 Carotid Artery Stents
5.1.2.4 Embolic Coils
5.1.2.5 Support Devices
5.1.3 Neurosurgery Devices
5.1.3.1 Neuroendoscopes
5.1.3.2 Stereotactic Systems
5.1.3.3 Aneurysm Clips
5.1.3.4 Other Neurosurgery Devices
5.1.4 Neurostimulation Devices
5.1.4.1 Spinal Cord Stimulation Devices
5.1.4.2 Deep Brain Stimulation Devices
5.1.4.3 Sacral Nerve Stimulation Devices
5.1.4.4 Other Neurostimulation Devices
5.1.5 Other Types of Devices
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun SE
6.1.2 Boston Scientific Corporation
6.1.3 Stryker Corporation
6.1.4 Medtronic PLC
6.1.5 Abbott Laboratories
6.1.6 Johnson and Johnson
6.1.7 Smith & Nephew
6.1.8 Nihon Kohden Corporation
6.1.9 MicroPort Scientific Corporation
6.1.10 Natus Medical Incorporated
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Mexico Neurology Devices Industry Segmentation
Neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, and traumatic brain injury, among others.
The Mexico neurology devices market is segmented by type of device (cerebrospinal fluid management device, interventional neurology device (interventional/surgical simulators, neurothrombectomy devices, carotid artery stents, embolic coils, and support devices), neurosurgery device (neuroendoscopes, stereotactic systems, aneurysm clips, and other neurosurgery devices), neurostimulation device (spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, and other neurostimulation devices), and other types of devices).
The report offers the value (in USD ) for the above segments.
| By Type of Device | |||||||
| Cerebrospinal Fluid Management Devices | |||||||
| |||||||
| |||||||
| |||||||
| Other Types of Devices |
Mexico Neurology Devices Market Research FAQs
What is the current Mexico Neurology Devices Market size?
The Mexico Neurology Devices Market is projected to register a CAGR of 6.20% during the forecast period (2024-2029)
Who are the key players in Mexico Neurology Devices Market?
Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC and B. Braun SE are the major companies operating in the Mexico Neurology Devices Market.
What years does this Mexico Neurology Devices Market cover?
The report covers the Mexico Neurology Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Mexico Neurology Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Mexico Neurology Devices Industry Report
Statistics for the 2024 Mexico Neurology Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Mexico Neurology Devices analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
